ThursdayNov 10, 2022 1:27 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues. The trial was acquired from Entheon Biomedical Corp. in July 2022. “The acquisition of the Phase 1 DMT study was done with an eye toward informing and accelerating the clinical path forward for CYB004, and we are very pleased with the progress so far,”…

Continue Reading

ThursdayNov 10, 2022 12:05 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” the event is scheduled to begin at 8:30 a.m. Pacific Time on Nov. 17, 2022. Interested parties should visit https://ibn.fm/5WHrj to register for and join the complimentary, Zoom webinar-based event. Once registered, participants may begin forwarding their questions for InMed’s management to Tribe Public at…

Continue Reading

ThursdayNov 10, 2022 11:36 am

TinyGemsBreaks – Tingo Inc. (TMNA) Announces Launch of Operations in Ghana, Entry into Landmark Trade Deal with the Kingdom of Ashanti

Tingo (OTC: TMNA) today announced that Tingo Mobile PLC (“Tingo Mobile”) has opened a head office in Accra, Ghana, and has launched nationwide operations. According to the update, Tingo Mobile’s business in Ghana is held through a wholly owned subsidiary, Tingo Mobile Ghana Ltd (“Tingo Ghana”). To coincide with the launch, Tingo Ghana has agreed on a landmark trade deal with the Kingdom of Ashanti, through the Ashanti Kingdom Investment Trust. Under the terms, the Ashanti Kingdom Investment Trust has committed to enroll a minimum of 2 million new members with Tingo within 120 days of signing and has agreed…

Continue Reading

WednesdayNov 09, 2022 2:22 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Deploys 25 More ASRs, K1 Blue Light Towers Across the US

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, announced that it has activated more machines across the country. According to the announcement, the deployed equipment consists of ASRs and one of Knightscope’s newest products, the K1 Blue Light Tower. Deployment locations include another California resort and casino, a privately owned global real estate investment, a development and management firm with 634 properties, a Colorado-based community-focused real estate and infrastructure owner, operator, lender and developer, as well as an Ohio college. The press release reads, “Today’s announcement reinforces Knightscope’s continued commitment to accelerate growth and make the United States…

Continue Reading

WednesdayNov 09, 2022 2:07 pm

TinyGemsBreaks – Tingo Inc. (TMNA) Announces Filing of Definitive Information Statement to Merge with MICT

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has filed a Definitive Information Statement with the U.S. Securities and Exchange Commission (“SEC”). The statement outlines the completion of the merger between Tingo Mobile PLC, a wholly owned Tingo subsidiary, with MICT Inc., a NASDAQ-traded financial technology company; the merger should be complete by the end of this month. Once the merger is finalized, MICT will issue Tingo shares of its common stock equal to 19.9% of MICT’s outstanding shares along with Series A and Series B convertible preferred stock. According to the announcement, MICT does plan to seek both shareholder…

Continue Reading

WednesdayNov 09, 2022 1:37 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Inks Distribution Deal for Expansion into Ireland, UK

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has signed a distribution agreement with Newgate Motor Group, one of Ireland’s best-known dealerships. The agreement calls for Newgate to serve as the marketing, sales, distribution and servicing agent for the Mullen I-GO in Ireland and the United Kingdom. As part of the agreement, Newgate will purchase initial units of I-GO for use in vehicle demonstrations, marketing and sales opportunities with potential customers. According to the announcement, Mullen anticipates delivering those I-GO samples by end of December 2022. With more than four decades of experience, Newgate Auto Group is well…

Continue Reading

WednesdayNov 09, 2022 10:30 am

TinyGemsBreaks — Cepton Inc. (NASDAQ: CPTN) Reports Financial Numbers, Business Updates for Q3 2022

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is reporting its third-quarter 2022 results. Highlights of the financial report include a 171% increase in product revenue, which totaled $1.8 million, and minimal development revenue coming in at $1.2 million. The company also reported third quarter 2022 GAAP net loss totaled $17.4 million compared to GAAP net loss of $7.9 million in the prior year period with Q3 2022 non-GAAP net loss reaching $13.2 million compared to non-GAAP net loss of $6.6 million in 2021. The report noted that full year 2022 revenue is still expected to…

Continue Reading

TuesdayNov 08, 2022 1:10 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Inks New 22-Device Contract with Florida College

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has signed an agreement to deploy 22 K1 Blue Light Towers at a Florida college. According to the announcement, many schools are ill-equipped to address campus safety challenges because of staffing shortages and budget constraints. Knightscope’s proprietary tech and devices provide key solutions to their challenges. The new college contract includes the retrofitting of 13 emergency call systems and the replacement of older, hardwired towers at two separate locations. The Florida college will be leveraging Knightscope’s cellular and satellite communications with solar power to offer students, faculty and visitors…

Continue Reading

TuesdayNov 08, 2022 12:55 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences 1st-Ever Study Evaluating DehydraTECH-CBD’s Effect on Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The company has evidenced the safety and efficacy of DehydraTECH-CBD in human hypertension studies. Strong connections exist between heart disease, hypertension and diabetes, with hypertension twice as frequent in diabetics and hypertensive patients at greater risk of developing diabetes. Diabetes, which prevents the body from making enough insulin and results in…

Continue Reading

MondayNov 07, 2022 1:49 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate its ability to cross the blood-brain barrier and was designed with a molecular target of topoisomerase II enzymes responsible for cleaving and recombing double-stranded DNA during cellular replication,” a recent article explains. “Since the beginning…

Continue Reading

Contact us: (512) 354-7000